Literature DB >> 12055411

Assessment of outcomes other than systolic and diastolic blood pressure: pulse pressure, arterial stiffness and heart rate.

R Asmar1, B Darne, M el Assaad, J Topouchian.   

Abstract

In recent years, studies have shown that parameters derived from the arterial pressure wave other than systolic and diastolic blood pressure provide important information on cardiovascular status. Among these parameters, pulse pressure, arterial stiffness and heart rate have emerged as independent markers of cardiovascular risk in different populations. Although a number of studies have used casual measurements of these parameters in a clinic setting, others have focused on their assessment under ambulatory conditions. The pulse pressure represents the amplitude of the pressure wave signal (systolic minus diastolic blood pressure), higher pulse pressure values having been reported in patients possessing cardiovascular risk factors. Close associations between a high pulse pressure and several surrogate end-points have been described. Furthermore, epidemiological studies have shown that a high pulse pressure is an independent predictor of hard end-points in several populations. Arterial stiffness represents one of the major haemodynamic factors determining pulse pressure. Pulse wave velocity, measured from the initial upstroke of the pressure wave, constitutes an established index of arterial stiffness. Studies have reported stiffer arteries in patients with cardiovascular pathology even at an early stage of disease. Close correlations between arterial stiffness and several surrogate markers have been reported, and arterial stiffness and its changes have recently been shown to be an independent predictor of hard end-points in patients with a high cardiovascular risk. Methods to evaluate arterial stiffness under ambulatory conditions are emerging. Heart rate represents the frequency of the cyclical strain of the arterial wall, clinical studies having shown that ambulatory heart rate is correlated to several surrogate markers. A few epidemiological studies have analysed the value of ambulatory heart rate as an independent predictor of hard end-points, but their positive findings need to be confirmed. The analysis of the pressure wave thus allows the determination of several haemodynamic indices other than systolic and diastolic blood pressure. Pulse pressure, arterial stiffness and heart rate constitute other outcomes that may be useful as additional factors in risk assessment for future therapeutic decision-making.

Entities:  

Mesh:

Year:  2001        PMID: 12055411     DOI: 10.1097/00126097-200112000-00012

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

1.  Education, household wealth and blood pressure in Albania, Armenia, Azerbaijan and Ukraine: findings from the Demographic Health Surveys, 2005-2009.

Authors:  Michael O Harhay; Jason S Harhay; Meera M Nair
Journal:  Eur J Intern Med       Date:  2012-12-14       Impact factor: 4.487

2.  Ambulatory cardiovascular activity and hostility ratings in women with chronic posttraumatic stress disorder.

Authors:  Jean C Beckham; Amanda M Flood; Michelle F Dennis; Patrick S Calhoun
Journal:  Biol Psychiatry       Date:  2008-08-09       Impact factor: 13.382

3.  The Effect of Dipping Tobacco on Pulse Wave Analysis among Adult Males.

Authors:  Areeg E Elemam; Nisreen D Omer; Neima M Ibrahim; Ahmed B Ali
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

4.  Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Jiann-Liang Lin; Tsai-Chung Li; Cho-Tsan Bau; Wayne Huey-Herng Sheu
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

5.  Associations between vascular risk factors and subsequent Alzheimer's disease in older adults.

Authors:  Hyewon Lee; Kiwon Kim; Yeong Chan Lee; Soyeon Kim; Hong-Hee Won; Tae Yang Yu; Eun-Mi Lee; Jae Myeong Kang; Matthew Lewis; Doh Kwan Kim; Woojae Myung
Journal:  Alzheimers Res Ther       Date:  2020-09-26       Impact factor: 6.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.